Dietary long-chain polyunsaturated fatty acids from different sources affect fat and fatty acid excretions in rats.
Several sources of long-chain polyunsaturated fatty acids (LCP) have been evaluated for infant-formula supplementation. These sources differ in their chemical structure [triglyceride (TG) or phospholipid (PL)], arrangement of fatty acids on the TG or PL backbone, fatty acid composition and presence of other lipid components. All of these characteristics influence fat digestion, may affect fat and fatty acid absorption, and hence, LCP bioavailability and metabolism in infancy. The main objective of this work was to establish the influence of different dietary LCP sources on overall fat and LCP absorption in early life. We compared fat and fatty acid excretions at weaning in rats fed control diets or diets supplemented with LCP as TG or PL. Two separate experiments were conducted. In Experiment 1, weanling rats were fed for 3 wk a control diet (C1), a diet with TG from tuna and fungal oils (TF-TG) or a diet with PL from pig brain concentrate (PB-PL). In Experiment 2, weanling rats were fed for 3 wk a control diet (C2), a diet containing egg-TG (EG-TG) or a diet containing egg-PL (EG-PL). Fat, mineral and saturated fatty acid excretions in feces were higher in rats fed PB-PL compared with those fed TF-TG diet. In Experiment 2, groups did not differ in fat and mineral excretions. However, the EG-PL group had lower fecal excretions of saturated fatty acids than the C2 and EG-TG groups. The 16:1(n-7), 18:1(n-9), 18:2(n-6) and 22:6(n-3) levels in feces were higher in the EG-TG group than in the EG-PL group. In summary, total fat and LCP excretions differed among rats fed diets supplemented with LCP from different sources.
Amate
L
L
Research and Development Department, Abbott Laboratories, 18004 Granada, Spain.
Gil
A
A
Ramírez
M
M
D000042:Absorption; D000818:Animals; D001923:Brain Chemistry; D002118:Calcium / Q000032:analysis; D004041:Dietary Fats / Q000493:pharmacokinetics*; D004042:Dietary Fats, Unsaturated / Q000493:pharmacokinetics / Q000494:pharmacology*; D004531:Eggs; D005227:Fatty Acids / Q000032:analysis / Q000378:metabolism*; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000494:pharmacology*; D005243:Feces / Q000737:chemistry; D005260:Female; D008055:Lipids / Q000032:analysis; D008274:Magnesium / Q000032:analysis; D008903:Minerals / Q000032:analysis / Q000378:metabolism; D010743:Phospholipids / Q000008:administration & dosage; D010758:Phosphorus / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D013552:Swine; D014280:Triglycerides / Q000008:administration & dosage; D014413:Tuna; D015430:Weight Gain / Q000187:drug effects
D004041:Dietary Fats; D004042:Dietary Fats, Unsaturated; D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; D008055:Lipids; D008903:Minerals; D010743:Phospholipids; D014280:Triglycerides; D010758:Phosphorus; D008274:Magnesium; D002118:Calcium